Krause Kevin Michael

Chief Strategy Officer at ANTX

Sold, on record
$201k
Dollars the filings state
Form 4 sales
2
Latest Jan 9, 2024
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ANTXAN2 Therapeutics, Inc.Chief Strategy Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice ANTXNotice
    Jan 2, 2024 2024

    Filed to sell 10,000 shares ($205k)

    Krause Kevin Michael, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale ANTXRoutine
    Jan 2, 2024 same day

    Sold 2,583 shares at $20.12 ($52k)

    Krause Kevin Michael, Chief Strategy Officer

    10b5-1 planSold 57.4% of holdings ($90k position)1,914 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale ANTXRoutine
    Jan 9, 2024 +7 days

    Sold 7,417 shares at $20.14 ($149k)

    Krause Kevin Michael, Chief Strategy Officer

    10b5-1 planSold 79.5% of holdings ($188k position)1,914 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Krause Kevin Michael
Source
Jan 9, 2024Jan 11, 2024ANTXChief Strategy OfficerForm 4 sale7,417$149k79.5%RoutineSEC
Jan 2, 2024Jan 4, 2024ANTXChief Strategy OfficerForm 4 sale2,583$52k57.4%RoutineSEC
Jan 2, 2024Jan 2, 2024ANTXOfficerForm 144 notice10,000$205kNoticeSEC